Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,751–8,775 of 27,380 studies, newest first · page 351 of 1096.

June 2022 25

  1. 2022-06-14

    Sleep, physical activity, sedentary behavior, and risk of incident dementia: a prospective cohort study of 431,924 UK Biobank participants

    ✓ Peer-reviewed Long-term cohort studies Molecular psychiatry

    Key finding: This study aimed to investigate independent and joint associations of these three modifiable behaviors with dementia risks. +3 more findings

  2. 2022-06-14

    Exploring the Impact of TREM2 in Tumor-Associated Macrophages

    ✓ Peer-reviewed TREM2 and immune genetics Vaccines

    Key finding: TREM2 is a transmembrane receptor of the immunoglobulin superfamily expressed in myeloid cells. +3 more findings

  3. 2022-06-14

    New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention

    ✓ Peer-reviewed TREM2 and immune genetics Cells

    Key finding: The exact pathogenic mechanisms of AD remain elusive, resulting in the fact that the current therapeutics solely focus on symptomatic management instead of preventative or curative strategies. +3 more findings

  4. 2022-06-14

    The Impact of Type 2 Diabetes in Parkinson's Disease

    ✓ Peer-reviewed Mild cognitive impairment Movement disorders : official journal of the Movement Disorder Society

    Key finding: Because it is a potentially modifiable metabolic state, with multiple peripheral and central targets for intervention, it may represent a target for alleviating parkinsonian symptoms and slowing progression to disability and dementia. © 2022 The Authors. +1 more finding

  5. 2022-06-14

    Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment

    ✓ Peer-reviewed Biomarkers Brain communications

    Key finding: Although recent studies have demonstrated the prognostic utility of plasma biomarkers of Alzheimer pathology or neurodegeneration, such as pTau-181 and NF-L, whether other plasma biomarkers can further improve prediction of cognitive decline is undetermined. +4 more findings

  6. 2022-06-13

    Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease

    ✓ Peer-reviewed Risk genes beyond APOE Brain pathology (Zurich, Switzerland)

    Key finding: Furthermore, we found significantly enlarged perivascular spaces in vessels devoid of cerebral amyloid angiopathy in FAD compared with SAD and CADASIL subjects. +1 more finding

  7. 2022-06-13

    Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts

    ✓ Peer-reviewed Disease mechanisms Acta neuropathologica

    Key finding: Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) and Alzheimer's disease neuropathologic change (ADNC) are each associated with substantial cognitive impairment in aging populations. +1 more finding

  8. 2022-06-13

    Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Longitudinal patterns of clinical decline differ between LPA and PCA but are heterogeneous and related to different patterns of topographic spread. +4 more findings

  9. 2022-06-12

    Cannabis in Palliative Care: A Systematic Review of Current Evidence

    ✓ Peer-reviewed End-of-life care Journal of pain and symptom management

    Key finding: Fifty-two studies (20 randomised; 32 non-randomised) with 4786 participants diagnosed with cancer (n = 4491), dementia (n = 43), AIDS (n = 235), spasticity (n = 16), NORSE syndrome (n = 1) were included.

  10. 2022-06-11

    Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial

    ✓ Peer-reviewed Treatments Brain stimulation

    Key finding: Our results depict that 5 Hz rTMS of the bilateral cerebellum is a promising, non-invasive treatment of cognitive dysfunction in AD patients. +3 more findings

  11. 2022-06-10

    Social Isolation and Incident Dementia in the Oldest-Old-A Competing Risk Analysis

    ✓ Peer-reviewed Risk factors Frontiers in psychiatry

    Key finding: Excluding participants with prevalent dementia, n = 1,161 individuals were included. +4 more findings

  12. 2022-06-10

    Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer's Disease

    ✓ Peer-reviewed Genetics Frontiers in molecular neuroscience

    Key finding: Here, we analyzed cell subtype proportion differences in AD compared to non-AD controls using 1037 post-mortem brain samples from six neocortical regions. +3 more findings

  13. 2022-06-10

    Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease

    ✓ Peer-reviewed End-of-life care Cells

    Key finding: Multiple studies have shown that many of the brain's immunological cells, specifically microglia and astrocytes, are involved in AD pathogenesis. +2 more findings

  14. 2022-06-10
  15. 2022-06-09

    Fear of Incompetence in Family Caregivers and Dementia Care Transitions

    ✓ Peer-reviewed Caregiving International journal of aging & human development

    Key finding: Research on interpersonal interaction dynamics in relationships between persons with dementia and their family caregivers has been limited. +4 more findings

  16. 2022-06-09

    Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: TSPO and x c - overexpression can be assessed by [ 18 F]DPA-714 and [ 18 F]FSPG, respectively, and correlate with the level of Aβ plaque deposition obtained with a PET amyloid tracer. +4 more findings

  17. 2022-06-08

    The application of technology to improve cognition in older adults: A review and suggestions for future directions

    ✓ Peer-reviewed Cognitive tests and assessment PsyCh journal

    Key finding: The rapidly increasing worldwide population of older adults, along with the increasing prevalence of cognitive impairment and dementia in this population, is a growing health-care problem. +4 more findings

  18. 2022-06-08
  19. 2022-06-08

    Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression

    ✓ Peer-reviewed TREM2 and immune genetics Oncoimmunology

    Key finding: Macrophages are the most abundant immune cell type within TAME, although their diversity in the TAME is not clear. +3 more findings

  20. 2022-06-07

    Associations Between Sleep Duration and Sensory Impairments Among Older Adults in China

    ✓ Peer-reviewed Risk factors Frontiers in aging neuroscience

    Key finding: Of the 17,668 respondents, 8,396 (47.5%) were men. +4 more findings

  21. 2022-06-07

    Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) R47H Variant Causes Distinct Age- and Sex-Dependent Musculoskeletal Alterations in Mice

    ✓ Peer-reviewed TREM2 and immune genetics Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

    Key finding: Male TREM2R47H/+ animals had decreased trabecular bone geometry but increased ultimate strain and failure force at 20 months of age versus WT. +3 more findings

  22. 2022-06-07

    Cyanidin-3-O-Glucoside Regulates the M1/M2 Polarization of Microglia via PPARγ and Aβ42 Phagocytosis Through TREM2 in an Alzheimer's Disease Model

    ✓ Peer-reviewed TREM2 and immune genetics Molecular neurobiology

    Key finding: Cyanidin-3-O-glucoside (C3G), a dietary anthocyanin found in many fruits and vegetables, has been reported as an antioxidant, anti-inflammatory, and antitumor agent. +3 more findings

  23. 2022-06-07

    Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model

    ✓ Peer-reviewed TREM2 and immune genetics The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: We report that selective loss of Tsc1 , a negative regulator of mTOR, in microglia in mice of both sexes, caused mTOR activation and upregulation of Trem2 with enhanced β-Amyloid (Aβ) clearance, reduced spine loss, and improved cognitive function in the 5XFAD AD mouse model. +3 more findings

  24. 2022-06-06

    Accelerated epigenetic aging in newborns with Down syndrome

    ✓ Peer-reviewed Genetics Aging cell

    Key finding: Targeted sequencing of GATA1 was performed in a subset of 184 newborns with DS to identify somatic mutations associated with transient abnormal myelopoiesis. +3 more findings

  25. 2022-06-06

    A multi-hit hypothesis for an APOE4-dependent pathophysiological state

    ✓ Peer-reviewed Genetics The European journal of neuroscience

    Key finding: The APOE gene encoding the Apolipoprotein E protein is the single most significant genetic risk factor for late-onset Alzheimer's disease. +3 more findings

Browse the library by subject, with the full score breakdown →